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Background: Pluripotency is characterized by a unique transcriptional state, in which lineage-specification genes
are poised for transcription upon exposure to appropriate stimuli, via a bivalency mechanism involving the
simultaneous presence of activating and repressive methylation marks at promoter-associated histones. Recent
evidence suggests that other mechanisms, such as RNA polymerase II pausing, might be operational in this process,
but their regulation remains poorly understood.
Results: Here we identify the non-coding snRNA 7SK as a multifaceted regulator of transcription in embryonic stem
cells. We find that 7SK represses a specific cohort of transcriptionally poised genes with bivalent or activating
chromatin marks in these cells, suggesting a novel poising mechanism independent of Polycomb activity.
Genome-wide analysis shows that 7SK also prevents transcription downstream of polyadenylation sites at several
active genes, indicating that 7SK is required for normal transcriptional termination or control of 3′-UTR length. In
addition, 7SK suppresses divergent upstream antisense transcription at more than 2,600 loci, including many that
encode divergent long non-coding RNAs, a finding that implicates the 7SK snRNA in the control of transcriptional
bidirectionality.
Conclusions: Our study indicates that a single non-coding RNA, the snRNA 7SK, is a gatekeeper of transcriptional
termination and bidirectional transcription in embryonic stem cells and mediates transcriptional poising through a
mechanism independent of chromatin bivalency.Background
Pluripotent cells such as embryonic stem cells (ESCs) are
able to generate all the cell types of the adult organism,
and thus can acquire different cell fates upon appropriate
stimuli. The majority (85%) of annotated genes in ESCs
experience transcription by RNA polymerase II (Pol II)
[1]. Nevertheless, only a subset of these genes is expressed
in a robust manner, and Pol II has been reported as being
paused at 39% of the annotated genes [1]. Transcription
start sites (TSSs) of many genes that are expressed at
very low levels are bivalent for activatory (tri-methylation
of histone H3 at lysine 4, H3K4me3) and inhibitory* Correspondence: t.kouzarides@gurdon.cam.ac.uk
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histone modifications [2], with transcription being re-
pressed primarily by Polycomb complexes catalyzing
tri-methylation of H3K27 [3,4]. However, the chromatin
structure of pluripotent cells is globally ‘open’ and more
transcriptionally permissive [5,6], and has been recently
suggested to be refractory to repression by Polycomb,
relative to differentiated cells [7]. Moreover, in an induced
ground pluripotent state [8], lineage-specification genes
exhibit even lower expression and, paradoxically, reduced
H3K27me3 [9]. In these conditions increased Pol II pausing
is seen at these loci, which may be an alternative mechan-
ism for maintenance of the transcriptional poised state.
Although recruitment of the Pol II machinery to the
TSS is the most widely studied mode of transcriptional
regulation, pausing of Pol II has recently emerged as a cen-
tral step in this process [10]. The small nuclear non-codingCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Castelo-Branco et al. Genome Biology 2013, 14:R98 Page 2 of 18
http://genomebiology.com/2013/14/9/R98RNA (ncRNA) Rn7SK/7SK has an important role in the
regulation of transcriptional pausing [11-13], but its
function in pluripotent cells has not been assessed. 7SK
is an abundant RNA of around 330 nucleotides, which
is transcribed by Pol III and is highly conserved across
jawed vertebrates [14]. 7SK is present in a small nuclear ri-
bonucleoprotein (snRNP) complex with proteins such as
hexamethylene bis-acetamide inducible 1 mRNA (HEXIM)
1/2, La-related protein 7, and methylphosphate capping
enzyme [12]. The 7SK snRNP has been shown to sequester
positive transcription elongation factor b (P-TEFb), a kin-
ase complex that phosphorylates Pol II, thereby preventing
elongation [11,13,15,16]. Binding of the 7SK RNA to
HEXIM leads to a conformational change of this protein,
facilitating its binding to and inactivation of the kinase do-
main of P-TEFb [12,17,18].
In this study, we investigated the role of 7SK in mouse
ESC transcription. We found that 7SK not only regulates
the transcription of a specific subset of genes with bivalent
marks, but also of genes solely with active chromatin
marks. Furthermore, 7SK prevents widespread upstream di-
vergent transcription and affects transcriptional termination
of specific genes. Our study places the ncRNA 7SK in a
central position in the control of transcription in ESCs.
Results
7SK ncRNA is a gene-specific transcriptional repressor in ESCs
To investigate the role of 7SK in the control of transcrip-
tion in pluripotent cells, mouse ESCs were nucleofected
with two distinct antisense oligonucleotides (ASOs)
targeting segments near the 5′ [13] or 3′ ends of the
7SK transcript. We observed a 70–85% knockdown of
7SK RNA levels after 3 hours, which was sustained at
6 and 24 hours (Figure 1A; see Additional file 1: Figure S1).
We tested the transcriptional effects on lineage-specification
genes such as Olig2 and Delta-like 1 (Dll1), which are
expressed at very low levels in mouse ESCs, and found
that levels of nascent and processed transcripts (hereafter
referred to as ‘total RNA’) were rapidly increased upon 7SK
knockdown (Figure 1A,B; see Additional file 1: Figure S1).
By contrast, pluripotency-associated genes, such as
Sox2 and Pou5f1 (Oct4), were not affected (Figure 1A;
see Additional file 1: Figure S1, and data not shown).
We investigated whether 7SK could mediate transcriptional
repression of lineage-specification genes in ESCs in a
naive ground pluripotent state, induced by switching from
serum-containing medium to 2i/LIF, a defined medium
containing inhibitors of the mitogen activated protein
kinase/extracellular regulated kinase (MEK/ERK) and
glycogen synthase kinase 3 (GSK3) pathways in combin-
ation with leukemia inhibitory factor [8]. We found that
7SK-repressed genes such as Dll1 and Olig2 were indeed
downregulated in 2i/LIF, whereas 7SK levels remained
unchanged (see Additional file 1: Figure S1). Moreover,7SK knockdown in ground-state conditions upregulated
total RNA of Dll1 and Olig2 (Figure 1B), but not Pou5f1
(Oct4) (see Additional file 1: Figure S1), to levels similar
to those seen in ESCs cultured in the presence of serum.
Nevertheless, we observed that transcriptional poising of
lineage-specific genes by 7SK in ESCs is more prominent
in serum conditions (Figure 1B).
Our results suggested that 7SK regulates the expression
of lineage-specification genes in ESCs. In order to deter-
mine the genome-wide effects of 7SK, we analyzed the
transcriptome of ESCs grown in serum-containing media,
after acute knockdown of 7SK for 6 hours. For this pur-
pose, we used strand-specific RNA sequencing (RNA-seq)
targeting total RNA, without poly(A)+ selection, and after
ribosomal RNA depletion (see Additional file 1: Figure S1).
Although the majority of the annotated genes were not
significantly affected by 7SK knockdown, we found a
cohort of 438 genes (including Dll1 and Nr4a2) that
were upregulated after 7SK knockdown by both ASOs
(Figure 1C, D; see Additional file 2: Figure S2) and 30 genes
that were downregulated at a fold-change threshold of 1.5
and estimated false discovery rate below 5% (see Additional
file 3: Table S1; see Additional file 4: Table S2). Gene
Ontology (GO) analysis indicated that genes upregulated
after 7SK knockdown are highly enriched for those involved
in transcription and (neural) development (see Additional
file 2: Figure S2). Downregulated genes showed no en-
richment, with an adjusted P-value of less than 0.01.
RNA-seq data indicated increased transcriptional activity
at upregulated genes throughout their loci, including
at intronic regions (Figure 1C, E; see Additional file 5:
Figure S3). Genes with significantly increased mRNA levels
(exonic counts) showed a similar increase in intron expres-
sion, whereas non-regulated highly expressed genes such as
c-Myc, Nanog, and Pou5f1 (Oct4) did not present higher
levels of intronic reads after 7SK knockdown (Figure 1E;
see Additional file 5: Figure S3). Thus, these results suggest
that 7SK represses the expression of nascent transcripts in
specific loci, consistent with its function as a gene-specific
transcriptional repressor.
7SK knockdown is associated with failed transcriptional
termination at specific loci
Unexpectedly, we found increased transcription flanking
several of these genes (for instance Cbx4, Figure 2A) and
originating from the same strand, indicating broad genomic
regions where transcriptional repression is mediated by
7SK. Genome-wide analysis showed strong upregulation of
transcription both upstream (antisense) and downstream
(sense) of genes after 7SK knockdown (Figure 2B, C; see
Additional file 6: Figure S4). We identified 1,894 genes with
increased downstream sense-strand read coverage after
7SK knockdown (Figure 2D; see Additional file 7: Table S3),
indicating continued production of transcripts downstream
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Figure 1 7SK ncRNA as a gene-specific transcriptional repressor in embryonic stem cells (ESCs). (A) qRT-PCR analysis of 7SK and Olig2 total
RNA (nascent and processed RNA), and Pou5f1 (Oct4) mRNA 6 hours after nucleofection of ESCs with antisense oligonucleotides (ASOs) targeting
the 5′ and 3′ segments of 7SK, with green fluorescent protein (GFP) and scrambled ASOs as control. Error bars represent standard error of the
mean (SEM) from 2 to 3 independent experiments. (B) Quantitative reverse transcription (qRT)-PCR analysis of Dll1 and Olig2 total RNA in ESCs 6
hours after nucleofection with 7SK 3′ ASOs. ESCs were grown in serum (Ser-Ser) or 2i/LIF medium (2i-2i), or were switched from 2i/LIF to
serum-containing media after nucleofection (2i-Ser). Error bars represent SEM from two independent experiments. (C) RNA sequencing (RNA-seq)
read coverage at the Dll1 locus. For this and all other genome browser images, read counts were normalized (see Materials and Methods),
averaged over biological replicates, and visualized with Ensembl. The plus (green) and minus (blue) strand reads are displayed in separate tracks.
(D) The 50 most significantly upregulated genes after 7SK knockdown (that is, having the lowest P-values) were sorted by fold change. Color
scale indicates expression relative to scrambled ASO mean (two biological replicates per ASO, assayed by RNA-seq). (E) Exonic and intronic
normalized RNA-seq read counts for Olig2, Irx2, Dll1, c-Myc, Nanog, and Pou5f1 (Oct4), averaged over replicates.
Castelo-Branco et al. Genome Biology 2013, 14:R98 Page 3 of 18
http://genomebiology.com/2013/14/9/R98of polyadenylation sites (PASs). For the vast majority
(86.2%) of these genes, transcription continued past the
annotated end site for at least 1kb (in 48.7% of cases,for up to 10 kb) before reaching another gene. This down-
stream transcriptional activity often extended further from
the initiating gene and across large chromosomal regions
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Figure 2 7SK knockdown is associated with failed transcriptional termination at specific loci. (A) RNA sequencing (RNA-seq) read
coverage plot showing that 7SK knockdown results in increased transcription across an extensive region (box) downstream of Eif4a3, including
Cbx4. The plus (green) and minus (blue) strand reads are displayed in separate tracks. (B) Mean change in RNA-seq read coverage around
protein-coding genes after 7SK knockdown. Log2 fold changes on the sense (blue) and antisense (red) strands were determined in 500 bp
windows, and averaged over genes. (C) Density scatter plots of normalized read counts for protein-coding genes and surrounding regions.
Counts from experiments in which ESCs were nucleofected with 5′ and 3′ 7SK ASOs (y-axis) are plotted against counts for ESCs nucleofected
with scrambled control ASOs (x-axis), to illustrate the overall change in expression levels after 7SK depletion. Color intensity indicates the density
of data points. Read counts were normalized by the total number of mapped reads per sample (see Materials and Methods), incremented by a
pseudocount of 1 to enable visualization on a logarithmic scale, and averaged over samples. (D) Heatmap of failed transcriptional termination
after nucleofection of ESCs with 7SK 5′ and 3′ ASOs. Each row represents a potential locus of failed transcriptional termination, centered at the
3′ end of the gene (polyadenylation site; PAS) and extending 100 kb upstream and downstream. Genes were ordered by first combining the
normalized read distributions about the PAS for the six samples into a single vector for each gene, and are displayed in order from the highest
average fold change (at the top) to the lowest.
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(Figure 2). These regions spanned a total of 9170 genes,
although they were not preferentially located in gene-rich
areas (see Additional file 8: Figure S5). Notably, genes with
failed transcriptional termination were not themselves
upregulated in response to 7SK knockdown (see Additional
file 8: Figure S5), indicating a specific effect of this knock-
down on the termination of transcription.
7SK ncRNA directly represses a subset of genes with
bivalent or active chromatin marks
To identify genes subject to direct repression by 7SK, while
controlling for indirect transcriptional changes due to failed
transcriptional termination at an upstream gene, we
implemented a background-reduction filter. For each gene
and sample, a background signal was estimated as the me-
dian read coverage (number of mapped reads per base pair)
over five 2 kb regions at distances of 1 to 3, 3 to 5, 5 to 7, 7
to 9, and 9 to 11 kb upstream of the gene. Only reads
mapped to the strand of the gene were counted. Segments
of the 2 kb regions that coincided with exons of other genes
annotated on the same strand were masked out, in order to
base the background estimate on intronic and intergenic
transcription only (for further description, please see
Materials and Methods). Using this approach, we identified
122 genes that were under direct 7SK repressive control
(see Additional file 9: Table S4). Although pausing has been
proposed to be associated with the tuning of expression of
active genes [10,19], the level of expression of the genes
repressed by 7SK in ESCs was substantially lower than
those unaffected by 7SK knockdown (Figure 3A). GO ana-
lysis indicated that 7SK-regulated genes are highly enriched
for those involved in transcription, metabolic processes,
and development/differentiation, highlighting the specificity
of 7SK-repression in ESCs (see Additional file 8: Figure S5).
Most of the 7SK-repressed genes (81.1%) were found to
be occupied by transcriptionally engaged and elongation-
competent Pol II at the TSS, as assessed by comparing our
data with a global run-on sequencing (GRO-seq) dataset
from mouse ESCs [1] (P = 1.34 × 10-21, Fisher’s exact test,
compared with 53.7% in the genome, 10989 out of 20465
genes and lincRNAs). In accordance with this, treatment
with flavopiridol, an inhibitor of positive transcription
elongation factor b (P-TEFb) abolished the increase in
nascent transcript levels by 7SK knockdown (Figure 3B).
There was a robust enrichment for bivalent genes [2]
among those repressed by 7SK (27.9%), in relation to the
ESC transcriptome (4.5%, P = 3.44 × 10-9, Fisher’s exact test)
(Figure 3C). Interestingly, 49.5% of the genes repressed
by 7SK were marked with H3K4me3 in the absence of
H3K27me3 (Figure 3C). As with all 7SK-repressed
genes, these genes exhibited low levels of expression in
ESCs (Figure 3D), suggesting that 7SK provides a novel
mechanism of repression for these genes in pluripotentcells, distinct from the established mechanism involving
Polycomb activity.
7SK ncRNA represses upstream divergent transcription
Interestingly, as indicated above, we found widespread
transcription upstream of the TSSs of annotated genes in
the antisense/divergent orientation (Figure 2B, C). Applying
conservative criteria to exclude loci where such divergent
transcription might be confounded with reads from neigh-
boring protein-coding genes (see Materials and Methods),
we identified 2676 genes with strong evidence of divergent
transcription within 5 kb upstream of annotated TSSs
(Figure 4; see Additional file 10: Table S5). We refer to these
transcripts as upstream divergent RNAs (udRNAs), and
note that such RNAs are also expressed in human ESCs
[20] (see Additional file 8: Figure S5). We found that 22.7%
of the udRNAs overlapped with divergent TSS-associated
RNAs previously detected in mouse (see Additional file 11:
Figure S6). RNA-seq read coverage indicated that these
udRNAs could extend several kilobases upstream of the
TSS (Figure 2B; Figure 4).
A recent study identified numerous long ncRNAs
(lncRNAs) transcribed from active promoters of protein-
coding genes in mouse ESCs in the divergent orientation
[21]. Of the loci searched for udRNAs here, 869 were
found to encode such upstream divergent lncRNAs, and
we detected udRNAs at 613 of those (70.5%; Figure 5A).
Moreover, we also observed a general trend for long
intergenic ncRNAs (lincRNAs) to be upregulated after
7SK knockdown in mouse ESCs. For the 2,057 lincRNAs
annotated in the Ensembl database, expression levels
were increased by 18% on average (geometric mean
for background-adjusted data) after 7SK knockdown
(see Additional file 3: Table S1; see Additional file 4:
Table S2; see Additional file 9: Table S4). This is a larger
increase than expected for any group of genes (P < 10-6,
randomization test).
Quantitative expression analysis showed that the majority
of detected udRNAs were upregulated by 7SK knockdown
(Figure 2B; Figure 4B), with 94.5% displaying a positive
fold change and 60.5% upregulated more than two-fold,
again consistent with the repressor role of 7SK. Of the
udRNAs overlapping with divergent lncRNAs [21], 44.69%
(274 of 613) were upregulated by more than two-fold after
7SK knockdown (see Additional file 11: Figure S6). We
found, in contrast to the 7SK-repressed lineage-specific
genes, that genes associated with 7SK-repressed udRNAs
were transcriptionally active (Figure 5B). Indeed, at least a
quarter of the active genes in ESCs were found to be associ-
ated with udRNA expression (Figure 5C), and 71.9% of the
genes associated with 7SK-repressed udRNAs were marked
with H3K4me3 alone (Figure 5D).
We found a striking overlap between udRNA RNA-seq
reads and GRO-seq data, which also identified Pol II
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Figure 3 7SK ncRNA directly represses a subset of genes with bivalent or active chromatin marks in embryonic stem cells (ESCs),
through a mechanism involving positive transcription elongation factor b (P-TEFb). (A) Box plot of RNA sequencing (RNA-seq) gene
expression values (reads per kilobase per million (RPKM); see Materials and Methods), averaged over the control antisense oligonucleotide (ASO)
samples, for genes that were upregulated (left, red), downregulated (middle, blue) and not significantly altered (right, green) by 7SK knockdown.
Data are shown for the set of genes considered for differential expression analysis (see Materials and Methods). (B) Quantitative reverse
transcription (qRT)-PCR analysis of 7SK, Olig2, and Hexim1 total RNAs, and for Dll1 and Hes1 nascent RNAs 6 hours after nucleofection of ESCs with
scrambled 7SK 3′ ASOs, in the presence or absence of flavopiridol. Error bars represent standard error of the mean (SEM) from two to three
independent experiments. (C) Histone modification status in mouse ESCs [2] for all protein-coding and long intergenic non-coding RNA (lincRNA)
genes larger than 1 kb (top), the subset expressed in ESCs (middle; RPKM > 5 in control ASO sample), and the subset directly repressed by 7SK
(bottom). Similar results were obtained when data were compared with those of Young et al. [79] (D) Box plots of gene expression values as in
panel (A), further stratified by chromatin mark status as in panel (C). *P < 0.05, **P < 0.01; Kolmogorov-Smirnov test.
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http://genomebiology.com/2013/14/9/R98engaged upstream of annotated genes in mouse ESCs [1]
(Figure 4A,C). Overall, 88.5% of 7SK-repressed udRNAs
were found to have transcriptionally engaged Pol II. The
role of 7SK in transcriptional pausing has been previously
shown to involve sequestering the P-TEFb kinase, thereby
preventing Pol II phosphorylation at serine 2 [12]. Treat-
ment with the P-TEFb inhibitor flavopiridol abolished the
increase in udRNA levels induced by 7SK knockdown(Figure 6A), confirming that Pol II can initiate and elongate
transcription at these loci. Similar results (Figure 6C) were
obtained after treatment with I-BET151 [22], an inhibitor
of bromo and extra terminal (BET) bromodomain proteins,
which recruit P-TEFb to acetylated histones and lead to
activation of transcription [22,23]. Similar to 7SK-repressed
genes, repression of udRNA transcription by 7SK was
more pronounced in serum-containing media than in
30
Scrambled ASO 
3
0
7SK 5' ASO 
3
0
7SK 3' ASO 
10
0
GRO-seq (Min et al.)
< Rbm34 
10
0
Scrambled ASO 
10
0
7SK 5' ASO 
10
0
7SK 3' ASO 
10
0
GRO-seq (Min et al.)
126,950,000 126,955,000 126,960,000 126,965,000 126,970,000 126,975,000
P
lu
s 
st
ra
n
d
M
in
u
s 
st
ra
n
d
A
0
lo
g
fo
ld
 c
ha
ng
e
0
7SK ASO over control
1100
0
Scrambled ASO
1100
0
7SK 5' ASO
1100
0
7SK 3' ASO
40
0
GRO-seq (Min et al.)
Pou5f1 > 
40
0
Scrambled ASO
40
0
7SK 5' ASO
40
0
7SK 3' ASO
40
0
GRO-seq (Min et al.)
35,502,000 35,503,000 35,504,000 35,505,000 35,506,000 35,507,000 35,508,000 35,509,000 35,510,000
P
lu
s 
st
ra
n
d
M
in
u
s 
st
ra
n
d
B
C
Figure 4 7SK represses upstream divergent transcription. (A) Ensembl genome browser image of the Rbm34 locus, showing normalized RNA
sequencing (RNA-seq) read coverage (mean of two biological replicates) for ESCs nucleofected with scrambled control antisense oligonucleotides
(ASOs) or 7SK ASOs. Published global run-on sequencing (GRO-seq) data for ESCs [1] indicated occupancy of transcriptionally engaged Pol II.
Purple box highlights upstream divergent RNA (udRNAs). The plus (green) and minus (blue) strand reads are displayed in separate tracks. (B)
Change in udRNA expression after 7SK knockdown for all 2676 genes (rows) with a detected udRNA. Colors indicate fold change on the antisense
strand in 50 bp windows around the transcription start site (TSS). (C) RNA-seq and GRO-seq read coverage at the Pou5f1 (Oct4) locus. The udRNA
region is highlighted in purple box. Note that different scales are displayed for plus/minus strand and GRO-seq tracks in panels (A) and (C).
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associated with diverse cellular processes (see Additional
file 12: Table S6). Strikingly, these genes were mostly
unaffected by 7SK knockdown (Figure 6B,D; see Additional
file 10: Table S5). A similar pattern was seen with
7SK-regulated udRNAs overlapping divergent lncRNAs
(Figure 6E), suggesting that 7SK prevents the coordinated
expression of this subset of lncRNA/mRNA gene pairs.
Discussion
Several classes of regulatory RNAs are emerging as import-
ant regulators of gene expression, cell-fate determination,and development [24-31]. ncRNAs, including microRNAs
[32] and lncRNAs [26], have been recently implicated in
the control of pluripotency. Our study shows that a single
ncRNA, 7SK, controls different aspects of transcription at
specific loci in ESCs (Figure 7). 7SK represses a very spe-
cific cohort of genes, including several that are pivotal in
lineage specification. A substantial proportion of the genes
whose expression levels increased after 7SK knockdown
do not have bivalent chromatin marks, but rather have
H3K4me3, indicating that 7SK may inhibit transcription
at a novel subset of gene loci where Polycomb repression
is not operational. These results are consistent with recent
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Figure 5 udRNAs overlap with divergent lncRNAs and are associated with transcriptionally active genes. (A) Venn diagram showing that 70.5%
of genes with an associated divergent lncRNA in the upstream region [21] overlap with udRNAs. (B) Box plot of RNA-seq expression values, averaged over
the control ASO samples, of genes associated with udRNAs, stratified by change in expression after 7SK knockdown (see also Figure 3A). (C) Venn diagram
showing the proportion of expressed genes (RPKM> 5 in control ASO samples) found to be associated with udRNAs. (D) Overlap between genes and
udRNAs with genomic regions enriched for histone modifications H3K4me3, H3K27me3 or both (bivalent) in mouse ESCs [2] (see also Figure 3C). Similar
results were obtained when comparing with Young et al. [79]. *P< 0.05, **P< 0.01; Kolmogorov-Smirnov test.
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http://genomebiology.com/2013/14/9/R98findings that pluripotent chromatin in general is refractory
to repression by Polycomb [7], and that H3K27me3 is
reduced at genes whose expression is lower in an induced
ground pluripotent state [9]. However, although elongation
has been characterized as a major regulator of transcription
of active genes in ESCs [9,19], our data suggest that 7SK
is not required for the fine-tuning of transcription of
these genes.
P-TEFb has been shown to regulate transcription and
cell fate during embryonic development in Caenorhabditis
elegans [33], Drosophila [34] and zebrafish [35], and 7SKexpression is increased upon ESC differentiation into neural
(neuronal and glial) lineages [30]. Therefore, we extended
our analysis to neural committed cell types: neural stem
cells (NSCs) [36] and oligodendrocyte precursor cells
(OPCs) [37]. In contrast to ESCs, we did not observe
effects on the expression of Olig2 total RNA, which is
expressed in higher levels in these cells, after 7SK
knockdown (see Additional file 13: Figure S7). Other
genes expressed at higher levels in these cells, such as
Sox9 (NSCs) and Sox2 (OPCs), were also not affected by
7SK. However, there was an increase in nascent transcript
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Figure 6 7SK represses upstream divergent RNAs (udRNAs) and long non-coding RNA (lncRNAs) but not their associated
transcriptionally active genes, and positive transcription elongation factor b (P-TEFb) is involved in udRNA transcription. (A)
Quantitative reverse transcription (qRT)-PCR analysis of Rbm34 and Mettl16 udRNAs 6 hours after nucleofection of embryonic stem cell (ESCs) with
scrambled or 7SK 3′ antisense oligonucleotides (ASOs), in the presence or absence of flavopiridol. Error bars represent standard error of the mean
(SEM) from two independent experiments. (B) qRT-PCR analysis of udRNAs adjacent to Rbm34, hnRNPL, and Mett1l6, and corresponding mRNAs 6
hours after nucleofection of mouse ESCs with control ASOs or ASOs targeting 7SK. ESCs were grown in serum (Ser-Ser) or 2i/LIF media (2i-2i), or
switched from 2i/LIF to serum media after nucleofection (2i-Ser). SEM from two to three independent experiments. (C) qRT-PCR analysis of 7SK
total RNA, c-Myc spliced mRNA, and Rbm34 and Mett1l6 udRNAs, 6 hours after nucleofection of ESCs with scrambled of 7SK 3′ ASOs, in the
presence or absence of I-BET151. Error bars represent SEM from two to three independent experiments. (D) Box plot depicting log2 fold changes
measured by RNA sequencing (RNA-seq) after 7SK knockdown of udRNAs and their associated genes in mouse ESCs. (E) Box plot depicting log2
fold changes measured by RNA-seq after 7SK knockdown in mouse ESCs of 7SK-regulated udRNAs overlapping divergent long intergenic
non-coding RNAs (lincRNAs) and their associated genes.
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http://genomebiology.com/2013/14/9/R98levels for specification genes such as Nr4a2, Hes1, and
Irx2 after 7SK knockdown in NSCs (see Additional file 13:
Figure S7). We found a similar increase in nascent tran-
scription of Dll1 and of genes involved in oligodendro-
cyte differentiation, such as the genes encoding for
myelin basic protein (Mbp) and 2′,3′-cyclic-nucleotide3′-phosphodiesterase (Cnp) after 7SK knockdown in OPCs
(see Additional file 13: Figure S7). These results indicate
that the repression of lineage specification/differentiation
genes by 7SK is maintained in neural lineage cell popu-
lations. In a manner analogous to Polycomb activity
[38], 7SK repression appears to affect different cohorts of
Paused transcription
repressed/poised genes
Bivalent
H3K4me3+
Upstream divergent transcription
 active genes
Pol II
Pol II Pol IIPol IIH3K4me3
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Figure 7 The non-coding RNA (ncRNA) 7SK has a central role in controlling transcription in embryonic stem cells. 7SK is required for the
repression of genes that are silent or expressed at a low level. Widespread failed transcriptional termination was also seen after 7SK knockdown.
7SK is a major regulator of transcriptional directionality, by preventing the transcription of upstream divergent RNAs (udRNAs).
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http://genomebiology.com/2013/14/9/R98genes depending on the transcriptional and developmental
state of the cell.
These results indicate that 7SK plays an important
role in the control of transcription of lineage specification/
differentiation genes in stem/progenitor cells. It has been
previously shown that disruption of the 7SK snRNP is
rapidly compensated for by the increased expression of
another component of the complex, HEXIM1 [39]. We
found upregulation of Hexim1 total RNA in both ESCs
(Figure 1D; see Additional file 11: Figure S6) and in OPCs
(see Additional file 13: Figure S7), suggesting a similar
feedback mechanism to control P-TEFb availability after
7SK depletion.
This study also identified two completely novel functions
of 7SK in preventing downstream (sense) and upstream
(antisense) transcription, at specific and distinct active
loci. The increased downstream sense transcription seen
after 7SK knockdown might be associated with failed tran-
scriptional termination by Pol II [40] or lengthening of 3′
untranslated regions (UTRs) [41]. The latter appears to be
considerably more frequent in neural lineages than in ESCs
[41]. 7SK might thus be a key component in restricting 3′
UTR length in certain cell types, including ESCs, through a
mechanism less active in differentiated neural cell types.Widespread upstream divergent antisense transcription
has previously been described in several species [21,42-49].
In ESCs, this phenomenon was primarily found to produce
short RNAs (20 to 90 nucleotides) [50]. Recent studies indi-
cated that some of these transcripts can extend up to 1,100
kb [51], and that a majority of lncRNAs expressed in mouse
ESCs derive from bidirectional transcription at active gene
promoters [21,52]. The results here extend these findings,
identifying novel loci of divergent upstream transcription,
extending over several kb upstream of the TSS. They also
indicate that 7SK plays a role in the expression of a subset
of these divergent lncRNAs. lncRNA/mRNA gene pairs
have been reported to show coordinated expression after
differentiation of ESCs [21]. However, our data indicate that
7SK represses divergent lncRNA expression specifically,
rather than that of the associated mRNA, implying that
neighboring lncRNA and coding genes can be regulated
through different mechanisms. Moreover, the degradation
of divergent antisense RNAs can be mediated by the
exosome [42,46,49,51], and our results suggest that
this might be complemented by the activity of 7SK in
preventing divergent upstream transcription. 7SK knock-
down also led to upregulation of udRNAs in NSCs and
OPCs (see Additional file 13: Figure S7), suggesting
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function of 7SK.
P-TEFb kinase complex is involved in the functions
of 7SK described here, as treatment with the P-TEFb
inhibitor flavopiridol (Figure 3, Figure 6) [51] suppressed
the transcription of poised genes and udRNAs after
7SK knockdown. In addition, I-BET151 prevented the
upregulation of udRNAs by 7SK knockdown (Figure 6),
indicating that bromodomain-containing protein 4 (BRD4)-
mediated P-TEFb recruitment is involved in the 7SK
upregulation of udRNAs. This effect was not as prominent
for Dll1 (see Additional file 11: Figure S6), which might
reflect an alternative role of BRD4 in the association of
P-TEFb with the inactive 7SK complex [39,53], rather
than inhibition of the recruitment of P-TEFb to the
chromatin. Alternative and/or complementary mechanisms
to P-TEFb are also likely to be required for 7SK-mediated
repression. For instance, divergent transcription and
failed termination, which are both affected by 7SK, can
be inhibited via gene looping [54,55]. The polyadenylation
complex factor Ssu72, which is a phosphatase of Pol
II, has been shown to be pivotal to these processes in
Saccharomyces cerevisiae [54,55]. Interestingly, transcrip-
tional termination and elongation in HIV can also be regu-
lated by a regulatory region of the HIV RNA genome, TAR
[56], which has some structural similarities with 7SK [12],
and has been proposed to displace 7SK to enable trans-
activation of HIV genes [57]. While this paper was under
revision, Sharp and colleagues published a paper describing
a novel regulatory system that controls promoter direc-
tionality, based on enrichment of canonical polyadenylation
signals and Pol II termination upstream of genes, and
enrichment of U1 small nuclear RNA (snRNA) sites down-
stream of the TSS, preventing premature termination of the
sense RNA [58]. Interestingly, SR proteins, which interact
with the U1 small ribonucleoprotein, have recently been
shown to be components of the 7SK complex [59]. These
mechanisms might be operational in the repression of
upstream transcription and control of termination by 7SK.
Most of the 7SK snRNP sequesters P-TEFb in an in-
active complex in the nucleoplasm [15-17,23,60,61],
and in nuclear speckles [13]. 7SK knockdown leads to
reorganization of proteins associated with interchromatin
granule clusters, including SR proteins [13], and these
events could be involved in the transcriptional events we
found here. Nevertheless, our results also indicate that
7SK repression operates at specific loci in the genome,
and thus, specific recruitment mechanisms may be in
place. Indeed, it has been recently shown that 7SK ncRNA
is a chromatin component [62], and transiently associates
with repressed genes [13]. Moreover, the 7SK snRNP com-
ponent HEXIM1 can be located at active gene promoters
in mouse embryonic fibroblasts [59]. Chromatin-modifying
enzymes, some of which have been shown to interact withncRNAs in mouse ESCs [26] and/or transcription factors,
are also among the candidates for potentially targeting
7SK to specific loci to act as gene-specific transcriptional
repressor. 7SK has been recently shown to interact with
the transcription factor high-mobility group A1 (HMGA1)
and to modulate its transcriptional activity in both P-TEFb-
dependent and P-TEFb-independent manners [63-65]. The
transcription factor c-Myc has also been shown to recruit
P-TEFb to active genes in mouse ESCs, and to modulate
transcriptional elongation [19]. Interestingly, c-Myc expres-
sion is decreased in ESCs cultured in 2i/LIF, but promotes
elongation only of a small subset of genes in ESCs grown in
serum-containing media [9], which implies that there are
other unknown factors regulating the promoter-specific
poising. P-TEFb can also be recruited by the super elong-
ation complex (SEC) to paused active genes in mouse
ESCs, while after differentiation, SEC is recruited to
activated developmental genes [66]. Further investigation
will determine if some of these molecules contribute to
the mechanism by which 7SK regulates the diverse tran-
scriptional outcomes identified here, and whether these
are related or independent events.
Conclusion
Our study reveals that the ncRNA 7SK acts as a repressor
of a cohort of poised genes in ESCs, and unexpectedly
modulates several other processes, including upstream
(antisense) and downstream (sense) transcription. The ac-
tions of 7SK, although widespread, primarily affect specific
sets of genes, indicating that mechanisms for targeting 7SK
to discrete genomic loci might be in place.
Materials and methods
Cell culture
Oct4-GiP ESC [67] were maintained in ES media
consisting of Glasgow Minimum Essential Medium
(GMEM) supplemented with 10% fetal calf serum for
ESCs (Biosera, Boussen, France), 0.1 mmol/L non-essential
amino acids, 2 mmol/l L-Glutamine, 1 mmol/l sodium
pyruvate, 0.1 mmol/l β-mercaptoethanol, 1x penicillin/
streptomycin and 106 units/L LIF (ESGRO, MilliporeCorp.,
Billerica, MA, USA). Alternatively, cells were grown in
2i/LIF media, based on GMEM and containing 10%
Knock-Out Serum Replacement (Life Technologies
Corp., Carlsbad, CA, USA), 1% fetal calf serum for
ESCs (Biosera or Sigma-Aldrich (St Louis, MO, USA)),
0.1 mmol/l non-essential amino acids, 2 mmol/l L-
glutamine, 1mmol/l sodium pyruvate, 0.1 mmol/l beta-
mercaptoethanol, 1 μmol/l PD0325901 (AxonMedChem,
Groningen, The Netherlands), 3 μmol/l CHIR99021
(AxonMedChem), 1x penicillin/streptomycin, and 106
units/L LIF (ESGRO; Millipore). In addition, 1 μg/ml puro-
mycin was added to ES Oct4-GIP cultures during expan-
sion. NSO4G NSCs [36] were grown in RHB-A medium
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penicillin/streptomycin and 10 ng/ml basic fibroblast
growth factor and epidermal growth factor (PeproTech,
Rocky Hill, NJ, USA). ES Oct4-GIP and NSO4G cells were
cultured in plates coated with 0.1% gelatin (Sigma-Aldrich).
Oli-neu OPCs [37] were cultured in plates coated with
0.01% poly-L-lysine (Sigma-Aldrich) and grown in Sato
media (with 340 ng/ml T3 and 400 ng/ml L-thyroxine;
Sigma-Aldrich) supplemented with 1% horse serum
(Invitrogen) as previously described [37]). OPCs were
lipofected with 100 nmol/l ASOs using Lipofectamine
2000 (Invitrogen). Opti-MEM I reduced serum medium
was used to prepare the complexes. Cells were incubated
with the complexes for 4 hours in DMEM (Invitrogen
Corp., Carlsbad, CA, USA) before replacing media with
the original. Flavopiridol and I-BET151 were used at 500
nmol/l for 6 hours. ASOs (1,000 pmol) were nucleofected
into mouse ESCs using the Mouse ES Cell Nucleofector
Kit (program A23; Lonza AG, Basel, Switzerland). NSO4G
cells were transfected with 400 pmol ASOs using the Cell
Line Nuclefector Kit V (program T20; Lonza AG). After
nucleofection, ESCs/NSCs were plated into gelatin-coated
wells, and collected with Qiazol (Qiagen Inc., Valencia, CA,
USA) at the indicated time points for RNA extraction.
ASOs (Table S7) were synthesized by Integrated DNA
Technologies (Coralville, IA, USA). Total RNA was isolated
from ESCs and NSO4G using the miRNeasy Extraction Kit
(Qiagen), with in-column DNAse treatment.
qRT-PCR
Genbank and Ensembl cDNA sequences were used to
design gene-specific primers in Primer 3 [68] or in the
Universal ProbeLibrary Assay Design Center (Roche
Applied Science, Indianapolis, IN, USA). The specificity
of the PCR primers was determined by in silico PCR
(UCSC Genome Browser) and Primer-BLAST (NCBI)
programs. PCR primers (see Additional file 14: Table S7.
were synthesized by Sigma-Aldrich. DNase-treated total
RNA was reverse-transcribed with random primers for 1
hour, using the High-Capacity cDNA Reverse Transcription
Kit; Applied Biosystems, Foster City, CA, USA), in accord-
ance with the manufacturer’s instructions. Each sample was
equally divided into two aliquots: a cDNA reaction tube,
and a negative control tube without reverse transcriptase
(RT-negative). Before qPCR analysis, both cDNA and
RT-negative samples were diluted 5 or 10 times, with
DNase/RNase-free distilled water (Ambion Inc., Austin,
TX, USA). qPCR reactions were performed in duplicate
or triplicate for each sample. Each individual PCR was
carried out with a final volume of 10 to 20 μl and 2.5 to
5 μl of diluted cDNA. The RT-negative setup was run
for a few samples in each run to discount genomic DNA
amplification. The Fast SYBR Green Master Mix (Ap-
plied Biosystems) was used in accordance with themanufacturer's instructions. A melting curve was obtained
for each PCR product after each run, in order to confirm
that the SYBR Green signal corresponded to a unique and
specific amplicon. Random PCR products were also run in
a 2 to 3% agarose gel to verify the size of the amplicon.
Standard curves were generated for each qPCR run,and
were obtained by using serial three-fold dilutions of a
sample containing the sequence of interest. The data
were used to convert Ct values to arbitrary units of the
initial template for a given sample. Expression levels in
all experiments were then obtained by dividing this
quantity by the value of the housekeeping gene TATA-
binding protein (TBP) in the 7SK knockdown experi-
ments (because TBP is not affected by 7SK knockdown;
data not shown) or 18S ribosomal RNA in the flavopiridol
and I-BET151 experiments (18S expression is not affected
by flavopiridol or I-BET151, whereas TBP expression is
affected by flavopiridol, but not by I-BET151; data not
shown). Alternatively, the ΔΔCt method was used.
Strand-specific RNA-seq
Total RNA was depleted from ribosomal RNA with the
Low Input Ribo-Zero™ rRNA Removal Kit (Epicentre
Biotechnologies, Madison, WI, USA). No poly(A)+ selection
was performed. Total RNA was then fragmented with RNA
fragmentation reagent (Ambion), purified using the RNeasy
MinElute Kit (Qiagen), and treated with alkaline phosphatase
(New England Biolabs, Beverly, MA, USA) for 30 minutes
at 37°C. The 5′ dephosphorylated RNA was then treated
with T4 polynucleotide kinase (New England Biolobs) for 60
minutes at 37°C. The resulting RNA (5′ mono-phosphoryl
and 3′ hydroxyl) was purified using the RNeasy MinElute
Kit (Qiagen), and ligated with RNA 3′ and 5′ adapters,
using the TruSeq Small RNA Sample Preparation Guide
(Illumina Inc., San Diego, CA, USA) in accordance with
the manufacturer’s instructions. Indexes 1 to 6 were used for
PCR amplification. Libraries were quantified by Bioanalyzer
(Agilent Technologies Inc., Wilmington, DE, USA) or
absolute qPCR with a KAPA Library Quantification ABI
Prism Kit (Kapa Biosystems Inc., Woburn, MA, USA and
Applied Biosystems), and sequenced (50 nt single-end
reads) on the HiSeq 2000 (Illumina).
RNA-seq data processing and expression analysis
Sequence reads were processed to remove any trailing
3′-adapter sequence using Reaper (version 12–048) [69,70]
with the following options: -3p-global 12/1/0/2 -3p-prefix
12/1/0/2 -3p-head-to-tail 1. Reads shorter than 20 nt after
trimming were discarded. The remaining sequences were
aligned to mouse genome assembly NCBIM37 (mm9) using
GSNAP version 2012-04-21 [71]. GSNAP options were
set to require 95% similarity and disable partial alignments
(−m 0.05 --terminal-threshold = 100 --trim-mismatch-
score = 0). To enhance alignment accuracy, GSNAP was
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and the RefSeq Genes and UCSC Genes tracks from
the UCSC Genome Browser database [73]. Reads that
coincided with ribosomal RNA genes from Ensembl
or ribosomal repeats in the UCSC Genome Browser
RepeatMasker track were excluded.
Expression levels were estimated for Ensembl genes by
summing the counts of uniquely mapped reads, requiring
that at least half the alignment overlap annotated exon
sequence. This criterion was designed to retain exonic
reads in cases where partial exons were annotated or reads
were suboptimally aligned at exon boundaries (however, we
noted that nearly identical expression values were obtained
if 100% exon overlap was required; data not shown).
For comparisons among genes, the read counts were
normalized by exon model length and the total number
of reads mapped to genes, to give reads per kilobase of
exon model per million mapped reads (RPKM) [74]. Genes
were classified as expressed if the mean of the control
sample RPKMs was greater than 5.
For analysis of changes in gene expression after
7SK knockdown, read counts were normalized to be
comparable across samples using the trimmed mean
of M-values (TMM) method implemented in the
Bioconductor package edgeR [75,76]. We obtained
very similar results with the alternative normalization
method proposed by Anders and Huber [77]. To esti-
mate expression fold change for regions upstream and
downstream of genes, read counts for these regions
were processed as the counts for genes: only uniquely
mapped reads were considered, and normalization was
carried out using the scaling factors determined for
annotated genes by the TMM method. The same scal-
ing factors were also applied for visualization of read
coverage along the genome.
To verify that the observed increase in expression
around genes could be observed independent of the use
of gene annotation in the normalization, we additionally
analyzed changes in distributions of reads after scaling
raw counts so that the total number of mapped reads
was identical between libraries. Specifically, read counts
were divided by the total number of mapped reads per
sample, and multiplied by the mean number of mapped
reads across samples. The results of this analysis are shown
in Figure 2C and confirmed trends observed with TMM
normalization (see Additional file 6: Figure S4).
Differentially expressed genes were identified with the
generalized linear model functions in edgeR, using a design
matrix with two explanatory variables: antisense oligo type
(anti-7SK or scrambled control) and experiment batch
(1 or 2). To conservatively rule out off-target effects,
model fitting and calling of differentially expressed genes
were performed separately for each of the two 7SK ASOs,
and the results intersected. When testing each 7SK ASO,genes with minimal evidence of expression were excluded
by requiring a read count exceeding one read per million
exonic reads in at least two samples. For all fold-change
estimates, TMM-normalized read counts were incremented
by a pseudocount of 1.
To identify genes with altered expression after 7SK
knockdown while controlling for failed termination of up-
stream genes, read counts were adjusted by subtracting an
estimate of local background transcription. For each gene
and sample, a background signal was estimated as the me-
dian read coverage (number of mapped reads per base pair)
over five 2 kb regions at distances of 1 to 3, 3 to 5, 5 to 7, 7
to 9, and 9 to 11 kb upstream of the gene. Only reads
mapped to the strand of the gene were counted. Segments
of the 2 kb regions that coincided with exons of other genes
annotated on the same strand were masked out, in order to
base the background estimate on intronic and intergenic
transcription only. Background estimates were scaled to ac-
count for the difference in size between the regions where
background was measured and the exonic size of the gene.
Expression values below the background were set to zero.
Thus, for each gene i, the background-adjusted read count
was computed as:
max 0; gi−li medianj
aij
bij
  
where gi is the unadjusted read count, li is the total exonic
size of the gene, and aij and bij are the read counts and size
(after masking exons) for the five associated regions (j = 1,
2, …, 5), from which the background signal was estimated.
Detection of udRNA transcriptional units
The search for udRNAs was conducted using RNA-seq
data for an equal number of control and knockdown sam-
ples to avoid introducing a bias towards udRNAs prefer-
entially expressed in either condition. For the results
described above, the 7SK 5′ ASO data were omitted, thus
leaving two biological replicates each for the scrambled
ASO and the 7SK 3′ ASO. Intergenic regions between
closely spaced (<10 kb) and divergently oriented protein-
coding genes were excluded from consideration, in order
not to confound the udRNA reads with those from coding
genes. For the remaining protein-coding genes, the 5 kb
region immediately upstream was examined. This limit
was motivated by a genome-wide trend for increased
upstream transcription within 5 kb, after 7SK knockdown
(Figure 2B). Upstream regions were considered putative
udRNA transcriptional units if there was a normalized
count of at least 10 uniquely mapped reads on the op-
posite strand relative to the coding gene in any of the
four RNA-seq samples. We regard this threshold as
conservative, because the trend for increased transcription
in upstream regions was apparent at lower read counts
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that the 5′ ASO data were only excluded for detection of
putative udRNA regions. All RNA-seq data were used
in the further analysis of those regions, such as calculation
of fold change between knockdown and control conditions.
Equivalent results were obtained when the 3′ ASO data
were excluded instead (see Additional file 11: Figure S6),
and the upregulation of udRNAs in all knockdown samples
was evident (see Additional file 6: Figure S4).
An additional criterion was applied to distinguish udRNAs
from failed termination regions extending across promoters
(we found that some promoters exhibited antisense
transcription, due to apparent failed termination of a
downstream gene on the opposite strand; Figure 2A). For
this purpose, read coverage at putative udRNA regions
were compared to estimates of background transcription in
a manner similar to the background adjustment described
in the preceding section on gene expression analysis. For
each gene, antisense read coverage was determined over
five 2 kb regions at distances of 1 to 3, 3 to 5, 5 to 7, 7 to 9,
and 9 to 11 kb downstream of the final TSS. Segments of
these 2 kb regions that coincided with exons annotated on
the opposite strand relative to the gene were masked out,
in order to base the background estimate on intronic and
intergenic transcription only. udRNA regions were required
to have a read coverage at least two-fold greater than each
of the five background regions (in at least one of the
four RNA-seq samples considered). Thus, for each gene
i, the threshold for normalized udRNA read count was
computed as:
max 10; 2 5000 max
j
cij
dij
  
where 5000 corresponds to the size of the udRNA region in
base pairs, and cij and dij are the read counts and size (after
masking exons) for the five associated regions (j= 1, 2, …, 5)
from which the background signal was estimated.
Overlap with known features
The level of overlap between known features and transcript
regions was calculated using the intersectBed function from
the bedTools package [78]. To avoid the likelihood of false-
positive overlaps biasing the results, we limited our analysis
to protein-coding genes and lincRNAs greater than 1 kb in
length. Promoters were defined as the region 5 kb upstream
and 1 kb downstream from the TSS, which were interro-
gated for the presence of known H3K4me3-enriched and/
or H3K27me3-enriched sites [2,79], TSS-associated RNAs
[43] and regions of engaged Pol II [1]. If necessary, feature
coordinates were mapped to mm9 using the liftOver utility
available from the UCSC Genome Browser website [80].
Transcripts were defined as having the feature if an overlap
of at least one base was detected between the featurecoordinates and the gene region coordinates. P-values
for the enrichment of these genomic features in 7SK-
responsive genes were calculated using Fisher's exact test
on the 2 × 2 contingency table.
For divergent lncRNA comparisons, we took the list of
1,667 divergent lncRNAs identified in murine ESCs by
Sigova et al. [21], and compared these against the 1 kb re-
gion upstream of the TSSs of the 17,984 genes considered
in our analysis. Any gene where this region intersected
a divergent lncRNA on the opposite strand was considered
to be associated with divergent lncRNA transcription.
This resulted in 869 divergent lncRNA genes, which were
compared with the 2,676 genes that had an associated
udRNA identified in the 1 kb upstream region.
Identification of genes with failed transcriptional
termination
Each gene was subdivided into 100 regions of equal
length, and the normalized read density (number of
reads per base, normalized as previously described)
was calculated for each bin for each sample. The 100
kb regions immediately upstream and downstream of
the gene were also segmented into 500 bins of 200
bases each, and the normalized read density was com-
puted. For each gene, regions of enrichment upstream
of the TSS or downstream of the PAS were identified
by searching for contiguous bins showing a minimum
read density of 0.005 (corresponding to an average nor-
malized read count of 1 within the 200 bp bin) within a
sliding window of 10 bins. The normalized read count
within these regions was determined, and all read
counts were thresholded to a minimum of 1 to circum-
vent problems with subsequent fold-change analysis.
The log2 fold change between the mean of each of the 7SK
knockdown sample pairs (7SK 5′ ASO and 7SK 3′ ASO)
and the control sample pairs was calculated. All genes
showing a downstream region greater than 1 kb in size
with a fold change greater than 1.5 were considered
potential candidates for failed transcriptional termin-
ation, and were interrogated to identify further candi-
dates within 100 kb upstream, which might represent
the initiating locus. Candidate genes were defined as
those actively transcribed, showing no evidence of up-
stream candidates (and so are likely themselves to be
the initiating locus), and with a downstream region of
enrichment greater than 3 kb.
Identification of extent of downstream divergent
transcription
For candidate genes where failed transcriptional termination
may originate, the read distribution in 200 bp bins over a
1 Mb window upstream and downstream of the PAS was
calculated using the Repitools [81] package in R. Genes
were ordered by first combining the normalized read
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vector for each gene, and are displayed from the highest
average fold change (at the top) to the lowest average fold
change. We identified accurate estimates for the size of the
failed termination region by segmenting the read counts in
the 1 Mb region downstream of the PAS using Bayesian
change point analysis from the bcp package in R [82]. Con-
tiguous segmented regions from the PAS with a mean nor-
malized read density greater than 0.01 were combined to
give the limits of the potential failed termination region.
Gene ontology analysis
GO analysis was performed with the goseq package in R
[83], which accounts for selection bias in RNA-seq analyses
when detecting enrichment of GO classes. Enrichment
P-values were adjusted using the Benjamini and Hochberg
multiple testing correction method [84].
Data access
RNA-seq data, including tracks suitable for viewing
on the UCSC Genome Browser, have been deposited
in the ArrayExpress repository [85] under accession
E-MTAB-1585.
Additional files
Additional file 1: Figure S1. (a) Quantitative reverse transcription
(qRT)-PCR analysis of 7SK total RNA levels in two independent
experiments in which embryonic stem cell (ESCs) were nucleofected with
antisense oligonucleotides (ASOs) targeting 7SK at a position near the 5′
or 3′ end of the RNA (7SK 5′ or 7SK 53′ ASO). Error bars represent
standard error of the mean (SEM) for qPCR technical replicates. (b)
qRT-PCR analysis of Dll1 total RNA levels when ESCs were nucleofected
with 7SK 5′ and 3′ ASOs. ESCs were replated after nucleofection and
collected after 6 hours. Error bars represent SEM for qPCR technical
replicates. (c) qRT-PCR analysis of 7SK, Dll1, Olig2, and Hexim1 total RNAs
in ESCs after switch to 2iLIF media for several passages. (d) qRT-PCR
analysis of Pou5f1 mRNA in ESCs 6 hours after nucleofection with 7SK
3′ ASO. ESCs were grown in serum (Ser-Ser) or 2iLIF media (2i-2i), or
switched from 2iLIF to serum media after nucleofection (2i-Ser). Error bars
represent SEM from two independent experiments. (e) qRT-PCR analysis
of Pou5f1 nascent RNA in ESCs 6 hours after nucleofection with 7SK 3′
ASO. Error bars represent SEM from three independent experiments. (f)
Sample preparation workflow for directional RNA sequencing (RNA-seq).
Mouse ESCs were transfected with ASOs, and total RNA was extracted
after 6 hours. Two independent experimental sets were used. Total RNA
samples were treated with DNAse and depleted for ribosomal RNAs, but
not enriched for polyadenylated RNAs. After RNA fragmentation and 5′
and 3′ end polishing, adapters were ligated to the RNAs, in accordance
with the instructions of the TruSeq Small RNA sample prep kit (Illumina).
The amplified DNA was clustered and run in an Hi-Seq instrument
(Illumina) to obtain single-end reads of 50 nucleotides in length.
Bioinformatic analysis was performed as described in the Materials and
Methods section. (g) Breakdown of the number of sequenced reads per
sample in the directional RNA-seq, including number of reads mapped to
the mouse genome.
Additional file 2: Figure S2. (a) Ensembl genome browser screenshot
showing normalized RNA-seq read coverage (mean of the two biological
replicates) at the Nr4a2 (Nurr1) locus. The plus (green) and minus (blue)
strand reads are displayed in separate tracks. (b) Gene Ontology terms
associated with 7SK-regulated genes. Enrichment P-values were adjusted
using the Benjamini and Hochberg multiple testing correction method.Additional file 3: Table S1. Genes with altered expression after 7SK
knockdown with two different antisense oligos.
Additional file 4: Table S2. All genes with altered expression after 7SK
knockdown.
Additional file 5: Figure S3. Box plots and scatter plot depicting log2
fold changes measured by RNA sequencing (RNA-seq) after 7SK
knockdown in mouse ESCs, by counting reads over exons and introns. Of
the 438 genes found to be upregulated after 7SK knockdown, only those
with introns are shown (397).
Additional file 6: Figure S4. Density scatter plots of normalized read
counts for protein-coding genes and surrounding regions. Read counts
from experiments in which embryonic stem cell (ESCs) were
nucleofected with antisense oligonucleotides (ASOs) targeting the 5′ and
3′ parts of 7SK (y-axis) were plotted versus counts for ESCs nucleofected
with scrambled control ASOs (x-axis), to illustrate the overall change in
expression levels after 7SK depletion. Color intensity indicates the
density of data points. Note the increased read coverage in
upstream and downstream regions in 7SK-depleted samples. Read
counts were normalized by the trimmed mean of M-values (TMM)
algorithm (see Materials and Methods) and incremented by a
pseudocount of 1 to enable visualization on a logarithmic scale.
Upstream and downstream 5 kb regions were selected as described
in Materials and Methods to avoid inclusion of segments from
neighboring genes.
Additional file 7: Table S3. Coordinates of genes with failed
transcriptional termination regions.
Additional file 8: Figure S5. (a) Gene-density analysis for failed
termination genes. Gene density was computed as the number of
unique genes (protein-coding genes and long intergenic non-coding
RNAs (lincRNAs) greater than 1 kb long) within a window of +/−100
kb around the end position (final polyadenylation site) of each gene.
The resulting distributions are shown for the 1,894 failed
transcriptional termination genes (red) versus all other genes (black).
In both sets, the majority of genes were found to have 0 to 10 genes
within the 200 kb window (failed transcriptional termination genes:
mean = 5.949, median = 5; other genes: mean = 5.391, median = 4). (b)
Box plot depicting log2 fold changes by RNA sequencing (RNA-seq)
after 7SK knockdown of downstream sense RNAs and their associated
genes in mouse embryonic stem cells (ESCs). (c) Gene Ontology
terms associated with 7SK-regulated genes, after background
correction. Enrichment P-values were adjusted using the Benjamini
and Hochberg multiple testing correction method. (d) Published poly
(A)-negative whole-cell RNA-seq data from human ESCs (ENCODE)
showed the presence of upstream divergent RNAs (udRNAs) (purple
box). The plus (green) and minus (blue) strand reads are displayed in
separate tracks.
Additional file 9: Table S4. Genes with altered expression after
7SK knockdown with antisense oligos and local background
adjustment.
Additional file 10: Table S5. Upstream divergent RNA (udRNA)
transcription units.
Additional file 11: Figure S6. (a) Venn diagram showing the overlap
between upstream divergent RNAs (udRNAs) and antisense transcription
start site (TSS)-associated (TSSa) RNAs at the TSS. (b) Venn diagram
showing that 44.69% (274 of 613) udRNAs overlapping with divergent
long non-coding RNAs (lncRNAs) were also upregulated after 7SK
knockdown. (c) Venn diagram showing the overlap between genes with
failed termination after 7SK knockdown (‘hotspot’ genes) and
7SK-regulated udRNAs. (d) Quantitative reverse transcription (qRT)-PCR
analysis of Hexim1 total RNA, and Dll1 nascent RNA, 6 hours after
nucleofection of embryonic stem cell (ESCs) with scrambled 7SK 3′
antisense oligonucleotides (ASOs) targeting the 3′ segments of 7SK, in
the presence or absence of I-BET151. Error bars represent standard
error of the mean (SEM) from two to three independent experiments.
(e) Box plot depicting log2 fold changes measured by RNA sequencing
(RNA-seq) after 7SK knockdown of udRNAs and their associated genes
in mouse ESCs, using either 7SK 5′ or 7SK 3′ ASO data for udRNA
detection.
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http://genomebiology.com/2013/14/9/R98Additional file 12: Table S6. Gene Ontology analysis of upstream
divergent RNAs (udRNAs).
Additional file 13: Figure S7. (A) Quantitative reverse transcription
(qRT)-PCR analysis of 7SK and Olig2 total RNA, and Sox9 mRNA levels after
nucleofection of neural stem cells (NSCs) with 7SK 5′ and 3′ antisense
oligonucleotides (ASOs), compared with scrambled and green fluorescent
protein (GFP) ASOs (control; CTRL). NSCs were replated after
nucleofection, and collected after 6 and 24 hours. Error bars represent
standard error of the mean (SEM) for two independent experiments.
(B, C) qRT-PCR analysis of (B) Hes1, Irx2, and Nr2a4 nascent RNA and
(C) Hes1 and Rbm34 udRNA after nucleofection of NSCs with 7SK 3′ ASOs
compared with scrambled ASO (CTRL). NSCs were replated after
nucleofection, and collected after 6 hours. Error bars represent standard
deviation (SD) of qPCR technical replicates. (D, E) qRT-PCR analysis of (D)
7SK, Sox2, Hexim1, and Olig2 total RNA, and Dll1, CNP, and MBP nascent
RNA and (E) Rbm34, hnRNPL, and Hes1 udRNA, Sox8OT (AK079380) total
RNA, and Sox10OT (Gm10863) spliced RNA after lipofection of Oli-neu
oligodendrocyte precursor cells (OPCs) with 7SK 3′ ASOs compared with
scrambled ASOs (CTRL). OPCs were collected after 6 and 24 hours. Error
bars represent SEM for three independent experiments.
Additional file 14: Table S7. Sequence of quantitative reverse
transcription (qRT)-PCR primers and antisense oligonucleotides.
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